The ‘responsive and professional’ team at Clifford Chance exhibits skill across a broad range of areas, including M&A, allegations of abuse of dominance, and employment disputes concerning claims of employer negligence. The group advises a number of notable clients, including Cinven, Sofinnova Partners, and Teva Santé. All co-leading the team, Thomas Baudesson has longstanding expertise in product liability litigation; David Tayar regularly advises clients on merger control investigations, and restrictive arrangements; Dominique Laymand maintains a compliance and ethics focused practice; and Olivier Gaillard focuses on commercial contracts and consumer law issues.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Responsive and professional team.’
Key clients
- Agria Vet Guide AB
- Archimed
- Ares Capital
- Cinven
- dsm-firmenich (formerly Royal DSM)
- Gland Pharma
- Neuraxpharm
- Pfizer
- Sofinnova Partners
- Stada
- Teva Pharmaceuticals
- Teva Santé
- Unilabs France
Work highlights
- Advised private equity firm Cinven on an agreement with Bayer AG to acquire its Environmental Science Professional (BESP) business for a total enterprise value of USD 2.6 bn.
- Advising Teva on all EU antitrust investigations concerning them, both with respect to allegations of abuse of dominance and anticompetitive agreements, which are currently pending before the Commission or the EU courts.
- Advising on French veterinary law regulation and practices with a specific focus on veterinary telemedicine.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
The lawyer(s) leading their teams.
Thomas Baudesson, David Tayar, Dominique Laymand, Olivier Gaillard